REDWOOD CITY, Calif.  – January 2, 2019 – Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today that John A. Orwin, President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, at 1:30 p.m. Pacific Standard Time in San Francisco, CA.

About Atreca, Inc.

Atreca is a privately held biotechnology company developing novel therapeutics based on a deep understanding of the human immune response. We focus in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling us to discover and develop novel immunotherapies. Atreca is advancing a pipeline of candidates designed to engage the human immune response in oncology and other indications, thus driving better therapeutic outcomes. For more information on Atreca, please visit www.atreca.com.

Contact

Atreca, Inc.
Susan Berland
EVP and Chief Financial Officer
info@atreca.com

Media:

Nancie Steinberg, 212-213-0006, ext. 318
nsteinberg@burnsmc.com

Robert Flamm, 212-213-0006, ext. 364
rflamm@burnsmc.comor

Investors:

Alex Gray, 212-213-0006, ext. 355
agray@burnsmc.com

Source: Atreca, Inc.